A pilot study in prostate cancer patients treated with the AE37 Ii-key-HER-2/neu polypeptide vaccine suggests that HLA-A*24 and HLA-DRB1*11 alleles may be prognostic and predictive biomarkers for clinical benefit

Eleftheria A. Anastasopoulou, Ioannis F. Voutsas, Theodora Keramitsoglou, Cécile Gouttefangeas, Hubert Kalbacher, A. Thanos, Michael Papamichail, Sonia A. Perez, Constantin N. Baxevanis

Cancer Immunology Immunotherapy · 2015 · 18 citations · 23 references

DOIFull text

Open access

Concepts

References

23